Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1995 1
1996 1
1997 1
1998 5
1999 1
2000 5
2001 4
2002 5
2003 3
2004 1
2005 5
2006 3
2007 3
2008 8
2009 7
2010 9
2011 12
2012 20
2013 17
2014 12
2015 20
2016 13
2017 8
2018 18
2019 13
2020 7
2021 10
2022 10
2023 8
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

220 results

Results by year

Filters applied: . Clear all
Page 1
Risk factors and disease mechanisms in myositis.
Miller FW, Lamb JA, Schmidt J, Nagaraju K. Miller FW, et al. Among authors: nagaraju k. Nat Rev Rheumatol. 2018 Apr 20;14(5):255-268. doi: 10.1038/nrrheum.2018.48. Nat Rev Rheumatol. 2018. PMID: 29674613 Free PMC article. Review.
Polymyositis and dermatomyositis: pathophysiology.
Nagaraju K, Lundberg IE. Nagaraju K, et al. Rheum Dis Clin North Am. 2011 May;37(2):159-71, v. doi: 10.1016/j.rdc.2011.01.002. Rheum Dis Clin North Am. 2011. PMID: 21444017 Review.
Immune-mediated pathology in Duchenne muscular dystrophy.
Rosenberg AS, Puig M, Nagaraju K, Hoffman EP, Villalta SA, Rao VA, Wakefield LM, Woodcock J. Rosenberg AS, et al. Among authors: nagaraju k. Sci Transl Med. 2015 Aug 5;7(299):299rv4. doi: 10.1126/scitranslmed.aaa7322. Sci Transl Med. 2015. PMID: 26246170 Free PMC article. Review.
Targeting necroptosis for the treatment of myositis.
Nagaraju K, Morales M. Nagaraju K, et al. Nat Rev Rheumatol. 2022 Jun;18(6):307-308. doi: 10.1038/s41584-022-00775-7. Nat Rev Rheumatol. 2022. PMID: 35388209 No abstract available.
Ryanodine channel complex stabilizer compound S48168/ARM210 as a disease modifier in dystrophin-deficient mdx mice: proof-of-concept study and independent validation of efficacy.
Capogrosso RF, Mantuano P, Uaesoontrachoon K, Cozzoli A, Giustino A, Dow T, Srinivassane S, Filipovic M, Bell C, Vandermeulen J, Massari AM, De Bellis M, Conte E, Pierno S, Camerino GM, Liantonio A, Nagaraju K, De Luca A. Capogrosso RF, et al. Among authors: nagaraju k. FASEB J. 2018 Feb;32(2):1025-1043. doi: 10.1096/fj.201700182RRR. Epub 2018 Jan 3. FASEB J. 2018. PMID: 29097503 Free PMC article.
Total Synthesis of Kopsinitarine E.
Nagaraju K, Ni D, Ma D. Nagaraju K, et al. Angew Chem Int Ed Engl. 2020 Dec 1;59(49):22039-22042. doi: 10.1002/anie.202011093. Epub 2020 Sep 30. Angew Chem Int Ed Engl. 2020. PMID: 32833268
Design, architecture and application of nanorobotics in oncology.
Saxena S, Pramod BJ, Dayananda BC, Nagaraju K. Saxena S, et al. Among authors: nagaraju k. Indian J Cancer. 2015 Apr-Jun;52(2):236-41. doi: 10.4103/0019-509X.175805. Indian J Cancer. 2015. PMID: 26853420 Free article. Review.
Animal models of myositis.
Nagaraju K, Plotz PH. Nagaraju K, et al. Rheum Dis Clin North Am. 2002 Nov;28(4):917-33. doi: 10.1016/s0889-857x(02)00026-1. Rheum Dis Clin North Am. 2002. PMID: 12506778 Review.
220 results